| Industry Range | | Price / Earnings | N/A | |
| Book Value | 5.74 | |
| Earnings Per Share | -$2.67 | |
| Price To Sales Ratio | 26.28 | |
| Price To Book Ratio | 3.10 | |
| Price To Tangible Book Ratio | 3.10 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 397.5M | |
| Float (MRQ) | 90.12% | |
| Shares Outstanding (MRQ) | 49.1M | |
| Short Interest as a % of Float (MRQ) | 4.09% | |
| Shares Held By Institutions (MRQ) | 42.7M | |
| Industry Range | | Sales | $35.2M | |
| Gross Margin | 90.49% | |
| Net Profit Margin | -369.64% | |
| EBIT Margin | -377.22% | |
| EBITDA Margin | -367.71% | |
| Operating Margins | -377.22% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 7.74 | |
| Quick Ratio (MRQ) | 7.74 | |
| Total Debt/Equity Ratio (MRQ) | 1.74 | |
| Debt/Common Equity Ratio (MRQ) | 1.74 | |
| Industry Range | | Return on Equity | -46.74% | |
| Return on Assets | -41.20% | |
| Asset Turnover | 0.11 | |
| Receivables Turnover | 5.24 | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | 11.20% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*PTGX does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.06%